New Clinical Trials of Nexvax2 Therapeutic Vaccine for Celiac Disease

Posted by Connie Veilleux on Sep 5, 2012 in Health/Research | 0 comments

New clinical trials are being conducted by ImmusanT to further test a vaccine, Nexvax2, for those with celiac disease. This vaccine would allow the body to become tolerant to gluten, which damages the small intestine in celiac patients. Gluten is found in wheat, rye, barley, and triticale.